STOCK TITAN

Surrozen (SRZN) grants director David Woodhouse 5,550 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Surrozen, Inc./DE director David J. Woodhouse received a grant of 5,550 stock options, giving him the right to buy 5,550 shares of Common Stock. The options have a conversion or exercise price of $30.14 per share and expire on May 12, 2036. According to the terms, the options vest and become exercisable on the anniversary of the grant date, subject to his continuous service as a director. After this grant, he holds 5,550 director stock options directly, and this filing reflects a compensation-related award rather than an open-market share purchase or sale.

Positive

  • None.

Negative

  • None.
Insider WOODHOUSE DAVID J
Role null
Type Security Shares Price Value
Grant/Award Director Stock Option (right to buy) 5,550 $0.00 --
Holdings After Transaction: Director Stock Option (right to buy) — 5,550 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 5,550 options Director stock option grant to David J. Woodhouse
Exercise price $30.14 per share Conversion or exercise price of granted options
Underlying shares 5,550 shares Common Stock underlying the options
Expiration date May 12, 2036 Option term end date
Post-grant option holdings 5,550 options Total options held directly after this award
Director Stock Option financial
"security_title: Director Stock Option (right to buy)"
conversion or exercise price financial
"conversion_or_exercise_price: 30.1400"
expiration date financial
"expiration_date: 2036-05-12T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: Common Stock"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WOODHOUSE DAVID J

(Last)(First)(Middle)
C/O SURROZEN, INC.
171 OYSTER POINT BLVD., SUITE 400

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Surrozen, Inc./DE [ SRZN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Director Stock Option (right to buy)$30.1405/13/2026A5,55005/13/2027(1)05/12/2036Common Stock5,550$05,550D
Explanation of Responses:
1. The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director.
/s/ Charles Williams, Attorney-in-Fact for David J Woodhouse05/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Surrozen (SRZN) report for David J. Woodhouse?

Surrozen reported that director David J. Woodhouse received a grant of 5,550 stock options. These options give him the right to buy 5,550 shares of Common Stock at a fixed exercise price as part of his director compensation.

What is the exercise price of the new Surrozen (SRZN) stock options?

The granted options have an exercise price of $30.14 per share. This means Woodhouse can purchase Surrozen Common Stock at $30.14 per share once the options vest and become exercisable under the award terms.

When do David J. Woodhouse’s Surrozen (SRZN) options vest and become exercisable?

The options vest and become exercisable on the anniversary of the grant date. Vesting is conditioned on Woodhouse’s continuous service as a director, meaning he must remain on the board through that anniversary date.

When do the newly granted Surrozen (SRZN) director stock options expire?

The stock options granted to David J. Woodhouse expire on May 12, 2036. After that expiration date, any unexercised options can no longer be used to purchase Surrozen Common Stock.

How many Surrozen (SRZN) stock options does David J. Woodhouse hold after this grant?

Following this transaction, Woodhouse holds 5,550 director stock options directly. All of these options relate to Surrozen Common Stock and result from the single grant reported in this Form 4 filing.

Is the Surrozen (SRZN) Form 4 transaction a market purchase or sale of shares?

No. The Form 4 reports a grant of stock options, not an open-market buy or sell of common shares. It is a compensation-related award for board service rather than a discretionary trade in the market.